CompletedNCT00169988
Sertraline alone or with risperidone for early psychosis symptoms
About this title
Read the official source — NCT00169988Medication studyAges 12–22United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 12 years to 22 years.
- Listed locations
- Glen OaksSee all locations and recruitment
Study information
Study start dateMarch 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 12 Years to 22 Years
- Official registry ID
- NCT00169988
- Official title
Show the full official title
Sertraline Alone vs. in Combination With Risperidone in the Treatment of Attenuated Positive and Negative Symptoms
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Did this study involve medication?
Yes. The study involved medication, including risperidone and sertraline-primary.
Who was this study for?
Listed age limits: 12 years to 22 years.
Want to explore more studies?
Explore studiesRelated studies
Paliperidone Injections Compared With Oral Medication for Schizophrenia
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia